New biomaterial developed by U of T engineering researchers could be delivered through minimally invasive surgery
A team of U of T engineering researchers is mending broken hearts with an expanding tissue bandage a little smaller than a postage stamp.
Repairing heart tissue destroyed by a heart attack or medical condition with regenerative cells or tissues usually requires invasive open-heart surgery. But now biomedical engineering Professor Milica Radisic and her colleagues have developed a technique that lets them use a small needle to inject a repair patch, without the need to open up the chest cavity.
Radisic’s team are experts in using polymer scaffolds to grow realistic 3D slices of human tissue in the lab. One of their creations, AngioChip, is a tiny patch of heart tissue with its own blood vessels – the heart cells even beat with a regular rhythm. Another one of their innovations snaps together like sheets of Velcro™.
Such lab-grown tissues are already being used to test potential drug candidates for side-effects, but the long-term goal is to implant them back into the body to repair damage.
“If an implant requires open-heart surgery, it’s not going to be widely available to patients,” says Radisic.
She says that after a myocardial infarction – a heart attack – the heart’s function is reduced so much that invasive procedures like open-heart surgery usually pose more risks than potential benefits.
“It’s just too dangerous,” she says.
From left to right, PhD candidate Miles Montgomery discusses his research with MP Peter Van Loan, Professor Milica Radisic and then Minister of State for Science and Technology Ed Holder, during a tour of U of T’s Institute for Biomaterials & Biomedical Engineering in 2014 (photo by Johnny Guatto)
Miles Montgomery, a PhD candidate in Radisic’s lab, has spent nearly three years developing a patch that could be injected, rather than implanted.
“At the beginning, it was a real challenge,” he says. “There was no template to base my design on, and nothing I tried was working. But I took these failures as an indication that I was working on a problem worth solving.”
After dozens of attempts, Montgomery found a design that matched the mechanical properties of the target tissue and had the required shape-memory behaviour: as it emerges from the needle, the patch unfolds itself into a bandage-like shape.
“The shape-memory effect is based on physical properties, not chemical ones,” says Radisic.
This means that the unfolding process doesn’t require additional injections and won’t be affected by the local conditions within the body.
The next step involved seeding the patch with real heart cells. After letting them grow for a few days, researchers injected the patch into rats and pigs. Not only did the injected patch unfold to nearly the same size as a patch implanted by more invasive methods, the heart cells survived the procedure well.
“When we saw that the lab-grown cardiac tissue was functional and not affected by the injection process, that was very exciting,” says Montgomery. “Heart cells are extremely sensitive, so if we can do it with them, we can likely do it with other tissues as well.”
The scaffold is built out of the same biocompatible, biodegradable polymer used in the team’s previous creations. Over time, the scaffold will naturally break down, leaving behind the new tissue.
The team also showed that injecting the patch into rat hearts can improve cardiac function after a heart attack: damaged ventricles pumped more blood than they did without the patch.
“It can’t restore the heart back to full health, but if it could be done in a human, we think it would significantly improve quality of life,” says Radisic.
There is still a long way to go before the material is ready for clinical trials. Radisic and her team are collaborating with researchers at the Hospital for Sick Children to assess the long-term stability of the patches, as well as whether the improved cardiac function can be maintained.
They have also applied for patents on the invention and are exploring the use of the patch in other organs, such as the liver.
“You could customize this platform, adding growth factors or other drugs that would encourage tissue regeneration,” says Radisic. “I think this is one of the coolest things we’ve done.”
The Latest on: Injectable tissue patch
- Profusa and Partners Announce Initiation of Study to Measure Early Signs of Influenza Through Biosensor Technologyon March 23, 2020 at 5:29 am
Profusa's Lumee Patch, a wireless reader that adheres to the skin and collects and reports tissue oxygen levels sensed by the Lumee Oxygen sensor to ... in the UK to be used in conjunction with other ...
- New Microarray Patch Delivers Vaccines Directly to the Skinon March 18, 2020 at 9:37 pm
‘New vaccine enables smaller doses of injection to many patients ... as rheumatic and connective tissue disease. The skin self examination means checking one’s own skin for any visible abnormal ...
- Oncology Injection Drug 2020 Global Trends, Market Size, Share, Status, SWOT Analysis and Forecast to 2026on March 18, 2020 at 1:06 am
WiseGuyRerports.com Presents “Global Oncology Injection Drug Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025” New Document to its Studies Database The ...
- Everything You Should Know About Ptosison March 15, 2020 at 5:03 am
(I still remember seeing my mom for the first time, after the patches I wore for a few weeks were removed ... It’s all invisible to the naked eye as it’s created behind the eyelid tissue. Because the ...
- Combined nucleus pulposus augmentation and annulus fibrosus repair prevents acute intervertebral disc degeneration after discectomyon March 11, 2020 at 11:30 am
Consequently, with the goal of preventing further herniation after discectomy and promoting healing and remodeling of the degenerated IVD, tissue-engineered and biomaterial approaches are of interest ...
- Combined Tissue Engineering Provides New Hope for Spinal Disc Herniations (2 of 2) (video)on March 11, 2020 at 11:08 am
His team developed a two-part injection to both reinflate and patch herniated discs, restoring the mechanical function and preventing further degeneration. This material relates to a paper that ...
- Radius Health: It Is Better To Wait And Seeon March 11, 2020 at 10:43 am
Tymlos market share gains remain consistent with the company's guidance. Delay in data readouts from Phase 3 wearABLe trial has reduced its incremental value potential. Plans to divest elacestrant and ...
- Gruesome accident prompts call to find alternative to needles in chemistry labson March 10, 2020 at 7:30 am
After two hours, the edges of the purple patch were turning black ... These include detailed animal studies that reproduce the accident, an analysis of tissue damage and a medical evaluation. Given ...
- Paclitaxel-induced peripheral neuropathy is caused by epidermal ROS and mitochondrial damage through conserved MMP-13 activationon March 4, 2020 at 2:17 am
We first wanted to analyze whether paclitaxel causes H 2 O 2 formation in epidermal keratinocytes and whether H 2 O 2 regulates MMP-13 expression. For this, we specifically expressed the H 2 O 2 ...
via Google News and Bing News